Nascent Pharma Holdings Inc (NASC)

[sleekscape]

CANB is positioned to be one of the top 3 largest revenue growers in the entire publicly traded cannabis sector of over 350 stocks in 2019, in terms of comparing year over year revenues

Q1 2018 revenues were $69,000

Q1 2019 should deliver over $500,000

That’s a 600% gain that will get the attention of many new investors

Q2 2018 revenues were $154,000

Q2 2019 should deliver $1M-$2M

This is the type of revenue growth in a startup that CBD investors are looking for in 2019

CANB will be a year over year and quarter over quarter revenue growth story in the rapidly growing Hemp-CBD sector

The Q1 financials will drop before May 16th, though CANB has a history of pre-announcing quarterly revenue so we may find out about Q1 results in April


Sleek